In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic® technology)

Bollettino Chimico Farmaceutico

Volumn 138, Issue 3, 1999, Pages 68-73

  Sangalli, M E ^a   Maroni, A ^a   Busetti, C ^b   Zema, L ^a   Giordano, F ^c   Gazzaniga, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Searle Liaea Poli   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; COLLOID TC 99M; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400; MESALAZINE; PENTETATE TECHNETIUM TC 99M; PHENAZONE; PHTHALIC ACID DIBUTYL ESTER; PLACEBO; POLYMER; SAMARIUM; TALC;

ADULT; CONFERENCE PAPER; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENTERIC COATED TABLET; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TABLET MANUFACTURE; TECHNOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; COLON; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; MALE;

EID: 0032968365     PISSN: 00066648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. V.H.K. Li, J.R. Robinson and V.H.L. Lee, Controlled Drug Delivery, M. Dekker, New York, 1987, p. 3.
2. A. Gazzaniga, U. Conte, P. Colombo, M.E. Sangalli, C. Caramella, A. La Manna, Polymers in medicine III, Elseviers Sci. Publishers, Amsterdam, 1988, p. 201.
3. S. Ueda, R. Ibuki, T. Hata, Y. Ueda, Proc. 15th Intern. Symp. Control. Rel. Bioact. Mater., 15, 450 (1988).
4. U. Conte, P. Colombo, A. La Manna, A. Gazzaniga, M.E. Sangalli, P. Giunchedi, Drug Dev. and Ind. Pharm., 15, 2583 (1989)
5. Patent EP 0 5 72 942 B I.
6. A. Gazzaniga, P. lamartino, G. Maffione, M.E. Sangalli, Boll. Chim. Farmaceutico 138, 78 (1993).
7. A. Gazzaniga, F. Giordano, M.E. Sangalli, L. Zema, S.T.P. Pharma, 4 (5), 336 (1994).
8. S.S. Davis, J. Controlled Rel., 2, 27 (1985).
9. M. Saffran et al., Science, 233, 1081 (1986).
10. K. Klokkers et al., J. Controlled Rel., 15, 105 (1991).
11. A. Gazzaniga, P. lamartino, G. Maffione, M.E. Sangalli, Int. J. Pharm., 108, 77 (1994).
12. A. Gazzaniga, M.E. Sangalli, F. Giordano, Eur. J. Pharm. Biopharm., 40, 246 (1994).
13. A. Gazzaniga, C. Busetti, M.E. Sangalli, R. Oriandi, S. Silingardi, F. Giordano, Proc. 15th Pharmaceutical Technology Conference, 1, 309 (1996).
14. A. Gazzaniga, C. Busetti, M.E. Sangalli, L. Moro, F. Giordano, S.T.P. Pharma, 5 (1), 83 (1995).
15. G. Maffione, P. lamartino, A. Gazzaniga, Proc. 10th Pharmaceutical Technology Conference, HI, 66 (1991); Drug Dev. and Ind. Pharm., 19, 2043 (1993).
16. G. Maffione, P. lamartino, A. Gazzaniga, Proc. 10th Pharmaceutical Technology Conference, HI, 66 (1991); Drug Dev. and Ind. Pharm., 19, 2043 (1993).
17. C.J. Van Boxtel, J.T. Wilson, S. Lindgren, F. Sjoqvist, Eur. J. Clin. Pharmacol., 9, 327 (1976).
18. Manuscript in preparation.